Please ensure Javascript is enabled for purposes of website accessibility

3 Stocks That Turned $3,000 Into More Than $15,000 in Just 1 Year

By Rich Duprey - Mar 20, 2017 at 11:47AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

We should think long term, but it's still exciting when our stocks make a big payoff in short order.

Warren Buffet famously said that the best time to sell a stock is never. While not even the Oracle of Omaha strictly adheres to that rule, investors still should have an appropriately long time horizon for the companies they put their money into. At least three to five years is a minimum; a decade is better, and decades is best.

Still, when companies make huge moves in a short period of time, it's worthwhile to see what the catalysts were that caused them to explode in value. Advanced Micro Devices (AMD -6.24%), Chemours (CC 1.21%), and KEMET (KEM) are three stocks that soared in value over the past year so that had you invested $3,000 in any one of them, you'd be looking at a $15,000 gain -- or better! Let's see why they made the moves they did.

AMD's new Ryzen chip for the gaming and virtual reality markets

Image source: Advanced Micro Devices.

Advanced Micro Devices

It was a long time coming, but Advanced Micro Devices posted its first adjusted profits in 2016. The last time the chipmaker was in the black, at least on a non-GAAP basis, was 2011, and after wandering in the wilderness for so long, it was a welcome homecoming.

The basis for the gains was its ability to carve out a niche supplying chips for the gaming industry as the PC business declined. Early on in 2016, it signed a deal with Tianjin Haiguang Advanced Technology Investment to license server chip designs for new processors for gaming consoles from Nintendo, Sony, and Microsoft, and it has recognized $88 million from the deal so far.

A lot of the sentiment in favor of AMD has depended on the ability of its Polaris, Vega, and Ryzen (aka Zen) architectures to gain share in the GPU and CPU markets, as well as sign more IP licensing deals with customers. By doing so, it has once again emerged as a competitive second source to Intel (INTC -2.20%), which it's planning to challenge with its new Ryzen processors and Naples server chips.  

However, the company is also reportedly willing to partner with its rival in a bid to take on NVIDIA. It will reportedly feature Intel's CPUs alongside its own GPUs in what can only be described as a case of "the enemy of my enemy is my friend."

There's still a lot of ground for Advanced Micro Devices to make up, but that seems to bode well for further gains in its stock, which has risen from well under $3 a share in March 2016 to over $14 a stub today. The 436% gain would have turned $3,000 into more than $16,000 in just one year.

A pipet gently releasing a clear liquid into a Petri dish

Image source: Chemours. 


Spun off from DuPont (DD) in 2015, performance chemicals specialist Chemours was seen as set up for failure from the beginning, with lots of debt and toxic assets its former parent wanted to shield itself from. The titanium dioxide market that had bolstered the balance sheets of DuPont, Dow Chemical, Kronos Worldwide, and Huntsman, the world's four largest producers of the white pigment, also imploded.

However, though it initially lost 85% of its value in its first seven months as a separate company, Chemours has gone on to be a star performer. It did so by cutting expenses and its workforce, and by shedding or shutting non-core assets. In 2016, Chemours reduced costs by $200 million, improved operating cash flows by $412 million, and retired $385 million in long-term debt. While the TiO2 business it inherited from DuPont is still weak, the performance chemicals leader was still able to raise prices last year, showing it still possesses substantial power in the industry and allowing it to more than double its adjusted earnings before interest, taxes, depreciation, and amortization margins to $157 million.

Shares of Chemours have gone from less than $7 each to over $33, a better than 400% gain that would have transformed $3,000 into more than $15,000. It still has some substantial risks ascribed to it, but it's a much better business than it was when it first hit the public markets.

A KEMET supercapacitor

Image source: KEMET.


The world's largest manufacturer of solid tantalum capacitors and one of the biggest makers of multilayer ceramic capacitors used across automotive, communications, and military and aerospace industries, KEMET has been on the rise since the November elections, perhaps on the promise by President Trump of increased infrastructure spending that would dwarf the stimulus spending package of his predecessor.

However, last month, KEMET's stock surged nearly 23% in one day after announcing it was acquiring NEC TOKIN, a Japanese manufacturer of tantalum capacitors, in which it had already owned a substantial stake. While the purchase brings new capabilities under KEMET's purview and enhances existing lines, there seems to be little reason for the outsized gains the deal generated.

When KEMET originally took a stake in TOKIN, regulators had no problem signing off on the deal because there were no competitive concerns raised, and it would only increase KEMET's market share incrementally. Of course, that was a few years ago, and now KEMET will own the entire company, but the playing field does appear to have been significantly altered to warrant the outsized gain.

Even so, KEMET's stock is up 440% over the past year, most of it since November, when it went from trading around $3.60 per share to today, where it stands north of $11 a share. That would mean it would have turned $3,000 into more than $16,000. Considering it had been trading sideways for much of 2016, those gains have largely occurred in about just four months' time, making its compounded growth rate really much larger.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Advanced Micro Devices, Inc. Stock Quote
Advanced Micro Devices, Inc.
$80.78 (-6.24%) $-5.38
Intel Corporation Stock Quote
Intel Corporation
$37.78 (-2.20%) $0.85
Microsoft Corporation Stock Quote
Microsoft Corporation
$256.48 (-3.17%) $-8.41
E. I. du Pont de Nemours and Company Stock Quote
E. I. du Pont de Nemours and Company
Sony Corporation Stock Quote
Sony Corporation
$83.19 (-1.49%) $-1.26
NVIDIA Corporation Stock Quote
NVIDIA Corporation
$159.82 (-5.26%) $-8.87
DuPont de Nemours, Inc. Stock Quote
DuPont de Nemours, Inc.
KEMET Corporation Stock Quote
KEMET Corporation
Nintendo Co., Ltd. Stock Quote
Nintendo Co., Ltd.
$54.15 (0.52%) $0.28
Kronos Worldwide, Inc. Stock Quote
Kronos Worldwide, Inc.
$19.17 (2.95%) $0.55
Huntsman Corporation Stock Quote
Huntsman Corporation
$28.72 (0.17%) $0.05
The Chemours Company Stock Quote
The Chemours Company
$31.73 (1.21%) $0.38

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.